Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VII: Challenging Clinical Questions
During the Dec. 8 virtual live event, a panel of experts will provide answers to common questions about COVID-19 that physicians face today.
23 Nov 2021
On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.
5 Oct 2021
Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
11 Jan 2022
ACP's personal protective equipment partner, Project N95, has an overstock of blue nitrile powder-free patient examination gloves available for immediate fulfillment.
13 Jul 2021
Topics covered will include current recommendations, immunizations in patients with high-risk chronic conditions, and strategies for increasing vaccination rates.
20 Jul 2021
The College's statement stresses that physicians have a responsibility to advocate for the health and well-being of patients and communities locally and globally and calls for a coordinated global vaccination effort to be ethical as well as practical.
22 Jun 2021
A virtual live event on June 9 will feature a panel of experts discussing current information on treating patients with persistent symptoms following acute SARS-CoV-2 infection.
25 May 2021
“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
15 Jun 2021
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
19 Oct 2021
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
14 Sep 2021